Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by 1H NMR spectroscopy

Journal of Proteome Research

Volumn 9, Issue 12, 2010, Pages 6265-6273

  Schicho, Rudolf ^a,b   Nazyrova, Alsu ^a   Shaykhutdinov, Rustem ^a   Duggan, Gavin ^a   Vogel, Hans J ^a   Storr, Martin ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CREATINE; DEXTRAN SULFATE; GLUCOSE; HYPOXANTHINE; KETONE BODY; MYELOPEROXIDASE; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; MALE; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SERUM; ULCERATIVE COLITIS; URINE; WEIGHT REDUCTION;

ANIMALS; CARNITINE; COLITIS, ULCERATIVE; CREATINE; DEXTRAN SULFATE; HYPOXANTHINE; KETONE BODIES; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; METHYLAMINES; MICE; MODELS, BIOLOGICAL; PRINCIPAL COMPONENT ANALYSIS; TIME FACTORS; TRYPTOPHAN;

ANIMALIA; MUS;

EID: 78649856207     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100547y     Document Type: Article

References (62)

1. Kappelman, M. D.; Rifas-Shiman, S. L.; Kleinman, K.; Ollendorf, D.; Bousvaros, A.; Grand, R. J.; Finkelstein, J. A. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States Clin. Gastroenterol. Hepatol. 2007, 5 (12) 1424-1429
2. Asakura, K.; Nishiwaki, Y.; Inoue, N.; Hibi, T.; Watanabe, M.; Takebayashi, T. Prevalence of ulcerative colitis and Crohn's disease in Japan J. Gastroenterol. 2009, 44 (7) 659-665
3. Hanauer, S. B. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities Inflamm. Bowel Dis. 2006, 12 (Suppl 1) S3-S9
4. Strober, W.; Fuss, I.; Mannon, P. The fundamental basis of inflammatory bowel disease J. Clin. Invest. 2007, 117, 514-521
5. Panteris, V.; Haringsma, J.; Kuipers, E. J. Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy Endoscopy 2009, 41 (11) 941-951
6. Crispin, A.; Birkner, B.; Munte, A.; Nusko, G.; Mansmann, U. Process quality and incidence of acute complications in a series of more than 230,000 outpatient colonoscopies Endoscopy 2009, 41 (12) 1018-1025
7. Chen, C.; Shah, Y. M.; Morimura, K.; Krausz, K. W.; Miyazaki, M.; Richardson, T. A.; Morgan, E. T.; Ntambi, J. M.; Idle, J. R.; Gonzalez, F. J. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis Cell Metab. 2008, 7 (2) 135-147
8. Lin, H. M.; Edmunds, S. I.; Helsby, N. A.; Ferguson, L. R.; Rowan, D. D. Nontargeted urinary metabolite profiling of a mouse model of Crohn's disease J. Proteome Res. 2009, 8 (4) 2045-2057
9. Lin, H. M.; Barnett, M. P.; Roy, N. C.; Joyce, N. I.; Zhu, S.; Armstrong, K.; Helsby, N. A.; Ferguson, L. R.; Rowan, D. D. Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease J. Proteome Res. 2010, 9 (4) 1965-1975
10. Martin, F. P.; Rezzi, S.; Philippe, D.; Tornier, L.; Messlik, A.; Hölzlwimmer, G.; Baur, P.; Quintanilla-Fend, L.; Loh, G.; Blaut, M.; Blum, S.; Kochhar, S.; Haller, D. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice J. Proteome Res. 2009, 8 (5) 2376-2387
11. Williams, H. R.; Cox, I. J.; Walker, D. G.; North, B. V.; Patel, V. M.; Marshall, S. E.; Jewell, D. P.; Ghosh, S.; Thomas, H. J.; Teare, J. P.; Jakobovits, S.; Zeki, S.; Welsh, K. I.; Taylor-Robinson, S. D.; Orchard, T. R. Characterization of inflammatory bowel disease with urinary metabolic profiling Am. J. Gastroenterol. 2009, 104 (6) 1435-1444
12. Bezabeh, T.; Somorjai, R. L.; Smith, I. C. MR metabolomics of fecal extracts: applications in the study of bowel diseases Magn. Reson. Chem. 2009, 47 (Suppl 1) S54-S61
13. 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease Am. J. Gastroenterol. 2001, 96 (2) 442-448
14. Jansson, J.; Willing, B.; Lucio, M.; Fekete, A.; Dicksved, J.; Halfvarson, J.; Tysk, C.; Schmitt-Kopplin, P. Metabolomics reveals metabolic biomarkers of Crohn's disease PLoS One 2009, 4 (7 e6386
15. 1H NMR metabolomics data Anal. Chem. 2006, 78 (13) 4430-4442
16. Murdoch, T. B.; Fu, H.; MacFarlane, S.; Sydora, B. C.; Fedorak, R. N.; Slupsky, C. M. Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice Anal. Chem. 2008, 80 (14) 5524-5531
17. Okayasu, I.; Hatakeyama, S.; Yamada, M.; Ohkusa, T.; Inagaki, Y.; Nakaya, R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 1990, 98, 694-702
18. Cooper, H. S.; Murthy, S. N.; Shah, R. S.; Sedergran, D. J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab. Invest. 1993, 69 (2) 238-249
19. Ni, J.; Chen, S. F.; Hollander, D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes Gut 1996, 39 (2) 234-241
20. 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects J. Pharm. Biomed. Anal. 2003, 33 (5) 1103-1115
21. Cohen, S. M.; Ohnishi, T.; Clark, N. M.; He, J.; Arnold, L. L. Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders Toxicol. Pathol. 2007, 35 (3) 337-347
22. Kimball, E. S.; Wallace, N. H.; Schneider, C. R.; D'Andrea, M. R.; Hornby, P. J. Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice Neurogastroenterol. Motil. 2004, 16 (6) 811-818
23. Krawisz, J. E.; Sharon, P.; Stenson, W. F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 1984, 87 (6) 1344-1350
24. 13C NMR spectroscopy of human blood plasma Anal. Chem. 1995, 67 (5) 793-811
25. 1H NMR metabonomics Anal. Chem. 2006, 78 (13) 4281-4290
26. Gauchi, J. P.; Chagnon, P. Comparison of selection methods of explanatory variables in PLS regression with application to manufacturing process data Chemometr. Intell. Lab. 2001, 58 (2) 171-193
27. Melgar, S.; Bjursell, M.; Gerdin, A. K.; Svensson, L.; Michaëlsson, E.; Bohlooly-Y, M. Mice with experimental colitis show an altered metabolism with decreased metabolic rate Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292 (1) G165-G172
28. Geier, M. S.; Butler, R. N.; Giffard, P. M.; Howarth, G. S. Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats Int. J. Food Microbiol. 2007, 114 (3) 267-274
29. Smith, J. L.; Wishnok, J. S.; Deen, W. M. Metabolism and excretion of methylamines in rats Toxicol. Appl. Pharmacol. 1994, 125 (2) 296-308
30. Takaishi, H.; Matsuki, T.; Nakazawa, A.; Takada, T.; Kado, S.; Asahara, T.; Kamada, N.; Sakuraba, A.; Yajima, T.; Higuchi, H.; Inoue, N.; Ogata, H.; Iwao, Y.; Nomoto, K.; Tanaka, R.; Hibi, T. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease Int. J. Med. Microbiol. 2008, 298 (5-6) 463-472
31. Mirvish, S. S. Formation of N-nitroso compounds: chemistry, kinetics, and in vivo occurrence Toxicol. Appl. Pharmacol. 1975, 31 (3) 325-351
32. Saijo, F.; Milsom, A. B.; Bryan, N. S.; Bauer, S. M.; Vowinkel, T.; Ivanovic, M.; Andry, C.; Granger, D. N.; Rodriguez, J.; Feelisch, M. On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease Nitric Oxide 2010, 22 (2) 155-167
33. Lee, R.; West, D.; Phillips, S. M.; Britz-McKibbin, P. Differential metabolomics for quantitative assessment of oxidative stress with strenuous exercise and nutritional intervention: thiol-specific regulation of cellular metabolism with N-Acetyl-l-Cysteine Pretreatment Anal. Chem. 2010, 82 (7) 2959-2968
34. 1H-NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery Biomarkers 2004, 9 (2) 156-179
35. Young, E. G.; Hawkins, W. W. The Decomposition of Allantoin by Intestinal Bacteria J. Bacteriol. 1944, 47 (4) 351-353
36. Chen, X. B.; Calder, A. G.; Prasitkusol, P.; Kyle, D. J.; Jayasuriya, M. C. Determination of 15N isotopic enrichment and concentrations of allantoin and uric acid in urine by gas chromatography/mass spectrometry J. Mass Spectrom. 1998, 33 (2) 130-137
37. Heimesaat, M. M.; Fischer, A.; Siegmund, B.; Kupz, A.; Niebergall, J.; Fuchs, D.; Jahn, H. K.; Freudenberg, M.; Loddenkemper, C.; Batra, A.; Lehr, H. A.; Liesenfeld, O.; Blaut, M.; Göbel, U. B.; Schumann, R. R.; Bereswill, S. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4 PLoS One 2007, 2 (7 e662
38. Kawaguchi, T.; Sakisaka, S.; Mitsuyama, K.; Harada, M.; Koga, H.; Taniguchi, E.; Sasatomi, K.; Kimura, R.; Ueno, T.; Sawada, N.; Mori, M.; Sata, M. Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis Hepatology 2000, 31 (6) 1285-1295
39. Kitajima, S.; Takuma, S.; Morimoto, M. Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis J. Vet. Med. Sci. 1999, 61 (1) 67-70
40. Jahnel, J.; Fickert, P.; Langner, C.; Högenauer, C.; Silbert, D.; Gumhold, J.; Fuchsbichler, A.; Trauner, M. Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice Liver Int. 2009, 29 (9) 1316-1325
41. Dou, L.; Jourde-Chiche, N.; Faure, V.; Cerini, C.; Berland, Y.; Dignat-George, F.; Brunet, P. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells J. Thromb. Haemost. 2007, 5 (6) 1302-1308
42. Niwa, T.; Ise, M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis J. Lab. Clin. Med. 1994, 124 (1) 96-104
43. Rothfuss, K. S.; Stange, E. F.; Herrlinger, K. R. Extraintestinal manifestations and complications in inflammatory bowel diseases World J. Gastroenterol. 2006, 12 (30) 4819-4831
44. Knight, C.; Murray, K. F. Hepatobiliary associations with inflammatory bowel disease Expert Rev. Gastroenterol. Hepatol. 2009, 3 (6) 681-689
45. Vicario, M.; Crespí, M.; Franch, A.; Amat, C.; Pelegrí, C.; Moretó, M. Induction of colitis in young rats by dextran sulfate sodium Dig. Dis. Sci. 2005, 50 (1) 143-150
46. Caudarella, R.; Rizzoli, E.; Pironi, L.; Malavolta, N.; Martelli, G.; Poggioli, G.; Gozzetti, G.; Miglioli, M. Renal stone formation in patients with inflammatory bowel disease Scanning Microsc. 1993, 7 (1) 371-379
47. Worcester, E. M. Stones from bowel disease. Endocrinol. Metab. Clin. North Am. 2002, 31 (4) 979-999
48. Fraser, J. S.; Muller, A. F.; Smith, D. J.; Newman, D. J.; Lamb, E. J. Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy Aliment. Pharmacol. Ther. 2001, 15 (8) 1131-1137
49. Hove, H.; Holtug, K.; Jeppesen, P. B.; Mortensen, P. B. Butyrate absorption and lactate secretion in ulcerative colitis Dis. Colon Rectum. 1995, 38 (5) 519-525
50. Vernia, P.; Caprilli, R.; Latella, G.; Barbetti, F.; Magliocca, F. M.; Cittadini, M. Fecal lactate and ulcerative colitis Gastroenterology 1988, 95 (6)) 1564-1568
51. Lundsgaard, C.; Hamberg, O.; Thomsen, O. O.; Nielsen, O. H.; Vilstrup, H. Increased hepatic urea synthesis in patients with active inflammatory bowel disease J. Hepatol. 1996, 24 (5) 587-593
52. Gassull, M. A.; Cabré, E. Nutrition in inflammatory bowel disease Curr. Opin. Clin. Nutr. Metab. Care 2001, 4 (6) 561-569
53. Buffinton, G. D.; Doe, W. F. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients Free Radic. Res. 1995, 22 (2) 131-143
54. Jarrett, P.; Duffill, M.; Oakley, A.; Smith, A. Pellagra, azathioprine and inflammatory bowel disease Clin. Exp. Dermatol. 1997, 22 (1) 44-45
55. Harkness, R. A. Hypoxanthine, xanthine and uridine in body fluids, indicators of ATP depletion J. Chromatogr. 1988, 429, 255-278
56. Jabs, C. M.; Sigurdsson, G. H.; Neglen, P. Plasma levels of high-energy compounds compared with severity of illness in critically ill patients in the intensive care unit Surgery 1998, 124 (1) 65-72
57. Forrest, C. M.; Youd, P.; Kennedy, A.; Gould, S. R.; Darlington, L. G.; Stone, T. W. Purine, kynurenine, neopterin and lipid peroxidation levels in inflammatory bowel disease J. Biomed. Sci. 2002, 9 (5) 436-442
58. Mabley, J. G.; Pacher, P.; Liaudet, L.; Soriano, F. G.; Hasky, G.; Marton, A.; Szabo, C.; Salzman, A. L. Inosine reduces inflammation and improves survival in a murine model of colitis Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284 (1) 138-144
59. Grimble, R. F. Nutritional modulation of immune function Proc. Nutr. Soc. 2001, 60 (3) 389-397
60. Mahoney, L. B.; Denny, C. A.; Seyfried, T. N. Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans Lipids Health Dis. 2006, 5, 13
61. Coates, M. D.; Mahoney, C. R.; Linden, D. R.; Sampson, J. E.; Chen, J.; Blaszyk, H.; Crowell, M. D.; Sharkey, K. A.; Gershon, M. D.; Mawe, G. M.; Moses, P. L. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome Gastroenterology 2004, 126 (7) 1657-1664
62. Ghia, J. E.; Li, N.; Wang, H.; Collins, M.; Deng, Y.; El-Sharkawy, R. T.; Côté, F.; Mallet, J.; Khan, W. I. Serotonin has a key role in pathogenesis of experimental colitis Gastroenterology 2009, 137 (5) 1649-1660